February 05, 2019
Rose
Patients suffering from a rare disorder previously were able to obtain the treatment for free from a small pharmaceutical company that offered it through an FDA program called “compassionate use.” In November, the FDA allowed Catalyst to distribute the drug, with exclusive rights to market it. The following month the company said it would sell Firdapse for $375,000 a year. In other news, lawmakers are inviting CEOs from seven major drug companies to testify on prices.
from Kaiser Health News http://bit.ly/2S98XuS
February 05, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Thousands Of Clients’ Health Reports Exposed By DNA-Testing Service- State Highlights: Holy Cross Hospital Opens $6.5M Unit In Chicago To Address Mental Health Needs; Rhode Island Studies Ways To Improve Troubled City Schools
- What Does Quitting Opioids Actually Look Like Inside The Brain?
- Membership-Based Primary Care Model Gets Boost As Advocate Aurora Expands System In Chicago Area
- Parsing Policy: Attempt To Have Courts Kill The Health Law Makes Sense Only To The GOP; What’s The Next Huge Idea To Lower Health Care Costs?
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment